These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37348256)

  • 1. Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis.
    Figueiredo GM; Tengan FM; Campos SR; Luna EJ
    Clinics (Sao Paulo); 2023; 78():100233. PubMed ID: 37348256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.
    He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA
    J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
    Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.
    Hajissa K; Islam MA; Hassan SA; Zaidah AR; Ismail N; Mohamed Z
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.
    Kayı İ; Madran B; Keske Ş; Karanfil Ö; Arribas JR; Psheniсhnaya N; Petrosillo N; Gönen M; Ergönül Ö
    Clin Microbiol Infect; 2021 Sep; 27(9):1242-1249. PubMed ID: 34116205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2 antibodies in schoolchildren in the city of São Paulo, 2020.
    Kamioka GA; Madalosso G; Albuquerque JOM; Costa SA; Ferreira PB; Sato APS; Glasser PR; Pino FA; Burihan PCPR; Carvalho ACA; Amorim ABP; Cavazzana CL; Aires CC; Kataoka APAG; Savani ESMM; Bessa TAF; Aguiar BS; Failla MA; Santos EAD; Brito EMT; Santos MCHD; Caldeira LAV; Silva SMSE; Zamarco LC; Fonseca SMS; Lima MMC; Marques IA; Mauro AMMF; Masi E
    Rev Saude Publica; 2023; 57(suppl 1):6s. PubMed ID: 37255117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
    Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
    PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.
    Liang Y; Sun Q; Liu Q; Pang Y; Tang S
    Front Public Health; 2023; 11():1044788. PubMed ID: 37900041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on SARS-CoV-2 seroprevalence: regional and worldwide.
    Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing rate of anti-SARS-CoV-2 antibodies between the first and second waves of COVID-19 in São Paulo, Brazil: A cross-sectional blood donors-based study.
    Moya Rios do Vale N; Roche Moreira Latini F; Prisco Arnoni C; Martins Parreira R; Batista Castelo Girão MJ; Pereira Cortez AJ; Carvalho de Souza Bonetti T
    Clinics (Sao Paulo); 2022; 77():100016. PubMed ID: 35272203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.
    Chisale MRO; Ramazanu S; Mwale SE; Kumwenda P; Chipeta M; Kaminga AC; Nkhata O; Nyambalo B; Chavura E; Mbakaya BC
    Rev Med Virol; 2022 Mar; 32(2):e2271. PubMed ID: 34228851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review.
    Vaselli NM; Hungerford D; Shenton B; Khashkhusha A; Cunliffe NA; French N
    PLoS One; 2021; 16(11):e0250541. PubMed ID: 34727115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.
    Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM
    EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.